How Often Are Osteosarcoma Follow-Up Scans Needed?
At a Glance
After osteosarcoma treatment, follow-up usually includes exams and imaging every 3 months for the first 2 years, every 4 to 6 months through year 5, and annually afterward. Chest and local-site scans, plus late-effect checks, are tailored to each patient.
Finishing treatment for osteosarcoma is a major milestone, but it marks the beginning of a new phase: survivorship and surveillance. Because osteosarcoma has a risk of returning (relapse) and treatments can cause long-term side effects, patients—whether children, teenagers, or young adults—will need a structured schedule of check-ups and scans [1].
A Typical Surveillance Timeline
While major medical guidelines (such as those from the NCCN and ESMO) provide standard frameworks for monitoring, your care team will tailor the exact schedule to your specific tumor, the type of surgery you had, and your overall risk.
For the first five years after treatment ends—when the risk of recurrence is highest—a typical schedule for physical exams and imaging looks like this:
- Years 1 and 2: Every 3 months
- Years 3, 4, and 5: Every 4 to 6 months
- Beyond Year 5: Annually [2]
What Kind of Scans Are Used?
At these visits, the medical team is primarily looking to see if the tumor has returned to its original location (local recurrence) or if it has spread to the lungs (pulmonary metastasis). Keep in mind that not every scan is performed at every visit.
- Chest Imaging: The lungs are the most common site for osteosarcoma to spread, making chest imaging a critical part of surveillance [3][4]. Your team may use traditional chest X-rays, Chest Computed Tomography (CT), or an alternating schedule of both. While a chest CT is much more sensitive for detecting tiny lung nodules [5], it also exposes patients to more radiation than an X-ray. Because young patients are vulnerable to cumulative radiation, care teams weigh the need for detailed images against radiation risks, often using pediatric low-dose CT protocols [6][7]. Note: If a scan shows a tiny nodule, it does not automatically mean the cancer has returned; many nodules are benign (non-cancerous).
- Local Site Imaging: To ensure the cancer has not returned to the original bone, the primary tumor site is regularly imaged [8]. Depending on the surgery, this might involve plain X-rays or Magnetic Resonance Imaging (MRI), which provides excellent detail of soft tissue and bone marrow [9][10]. If the patient had limb-salvage surgery (surgery that removes the tumor while preserving the arm or leg) with metal implants, the metal can cause artifacts—distortions or blank spots on an MRI. In those cases, teams may use special MRI techniques or, selectively, an FDG PET/CT (a scan using a safe, glucose-like radioactive tracer) to evaluate the area [11].
Monitoring for Late Effects
Survivorship care isn’t just about looking for cancer; it is also about monitoring for the long-term impacts of intensive treatment. Depending on the specific chemotherapy drugs used, the annual survivorship exams may include monitoring heart function (if doxorubicin was used), checking kidney health and hearing (if cisplatin was used), and assessing bone growth and joint function.
Navigating Life Between Scans
The intense monitoring in the first two years can be exhausting, and the fear of recurrence—often called “scanxiety”—is very real for families. It is important to know that surveillance aims to identify any possible recurrence early while it may still be treatable, but you should not wait for a scheduled scan if you notice concerning changes. Contact your oncology team if you or your child experience new, persistent pain or swelling at the surgery site, changes in how the limb functions, unexplained fevers, a persistent cough, or chest pain.
Common questions in this guide
How often are follow-up scans needed after osteosarcoma treatment?
Why are chest scans part of osteosarcoma follow-up?
Which scans check the original osteosarcoma site?
How is radiation exposure managed during osteosarcoma surveillance?
What symptoms should prompt a call between scheduled scans?
What late effects are checked during osteosarcoma survivorship visits?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific surgery and implants, what is the best imaging modality for monitoring the local tumor site?
- 2.How are we balancing the need for detailed chest images with the goal of minimizing cumulative radiation exposure?
- 3.Which specific late effects (such as heart, hearing, or kidney issues) apply to my treatment history, and who will monitor them long-term?
- 4.Who should I contact if I develop new symptoms like bone pain or a cough between scheduled scans?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Osteosarcoma.
Beird HC, Bielack SS, Flanagan AM, et al.
Nature reviews. Disease primers 2022; (8(1)):77 doi:10.1038/s41572-022-00409-y.
PMID: 36481668 - 2
Beyond 5-year survival. A report from the Cooperative Osteosarcoma Study Group (COSS).
Fernandes JS, Blattmann C, Hecker-Nolting S, et al.
Cancer medicine 2024; (13(1)):e6893 doi:10.1002/cam4.6893.
PMID: 39102672 - 3
ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update.
, Stanborough R, Demertzis JL, et al.
Journal of the American College of Radiology : JACR 2022; (19(11S)):S374-S389 doi:10.1016/j.jacr.2022.09.015.
PMID: 36436964 - 4
Osteosarcoma Metastasis to the Thorax: A Pictorial Review of Chest Computed Tomography Findings.
Alduraibi KA, Towhari JA, Alebdi HA, et al.
Diagnostics (Basel, Switzerland) 2024; (14(18)) doi:10.3390/diagnostics14182085.
PMID: 39335763 - 5
Advances in the management of osteosarcoma.
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L
F1000Research 2016; (5()):2767 doi:10.12688/f1000research.9465.1.
PMID: 27990273 - 6
ESR Essentials: imaging of common paediatric pulmonary diseases-practice recommendations by the European Society of Paediatric Radiology.
Lovrenski J, Raissaki M, Plut D, et al.
European radiology 2025; (35(8)):5037-5052 doi:10.1007/s00330-024-11268-4.
PMID: 39881039 - 7
Radiological Imaging in Chest Diseases: Moving Away from Conventional Modes.
Bhatia A, Jana M, Chaluvashetty SB, et al.
Indian journal of pediatrics 2023; (90(8)):798-805 doi:10.1007/s12098-023-04615-8.
PMID: 37273132 - 8
Impacts of Tumor Location, Nature and Bone Destruction of Extremity Osteosarcoma on Selection of Limb Salvage Operative Procedure.
Chen Y, Yu XC, Xu SF, et al.
Orthopaedic surgery 2016; (8(2)):139-49 doi:10.1111/os.12237.
PMID: 27384722 - 9
Multiparametric MRI evaluation of bone sarcomas in children.
Inarejos Clemente EJ, Navarro OM, Navallas M, et al.
Insights into imaging 2022; (13(1)):33 doi:10.1186/s13244-022-01177-9.
PMID: 35229206 - 10
Pediatric Osteosarcoma: Correlation of Imaging Findings with Histopathologic Features, Treatment, and Outcome.
Nguyen JC, Baghdadi S, Pogoriler J, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2022; (42(4)):1196-1213 doi:10.1148/rg.210171.
PMID: 35594197 - 11
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.
Sharp SE, Shulkin BL, Gelfand MJ, McCarville MB
Pediatric radiology 2017; (47(13)):1800-1808 doi:10.1007/s00247-017-3963-1.
PMID: 28887617
This page is for informational purposes only and does not replace professional medical advice. Your oncology team should tailor the scan schedule and survivorship monitoring to your treatment, surgery, age, and recurrence risk.
Get notified when new evidence is published on Osteosarcoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.